Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Redefining Healthcare: Prioritizing in Remote Patient Monitoring

Remote Patient Monitoring (RPM) is using digital tools to provide care beyond traditional clinical settings, improving patient outcomes and reducing costs. Tools like Tripolo are helping these efforts by integrating technology into smart homes and facilitating personal communication between patients and providers. This shift towards digital solutions in healthcare supports patient independence and caters to those with chronic conditions or who are aging in place.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By Healthcare ·
Share
Redefining Healthcare: Prioritizing in Remote Patient Monitoring

Key takeaways

01

Remote Patient Monitoring (RPM) improves patient care by leveraging digital tools outside of traditional clinical settings.

02

Clinically validated and affordable digital tools enable effective healthcare delivery, particularly for chronic and aging patients.

03

Platforms like Tripolo enhance healthcare accessibility by integrating RPM with smart home technology.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

This report underscores the potential of remote patient monitoring (RPM) as a breakthrough element in patient-centric healthcare. It discusses the incorporation of digital technology for monitoring patients outside of clinical settings, with various affordable, clinically validated tools playing a vital role in improving patient outcomes. The report draws on industry-leading platforms, such as Tripolo and their customized offerings, providing insights into the overarching impact of RPM in healthcare.

Introduction

Reflecting the strategic emphasis on patient independence and improved clinical outcomes, this case study explores evolving RPM technology, particularly for chronic and aging patients. By analyzing the application of these digital tools and their contribution to the healthcare landscape, we assess their relevance in democratizing patient care.

Findings

For patients experiencing chronic conditions or aging in place, conventional in-person care is often impractical. Herein lies the value of RPM that allows effective monitoring outside of clinical settings. The effectiveness of such monitoring is contingent on the accuracy of the technology, highlighting the importance of clinically validated tools. Integrating these tools into smart connected homes paves the way for cost-effective and convenient healthcare solutions.

Discussion

A shift towards patient independence and improved clinical outcomes necessitates an exploration of alternative solutions. One viable alternative is the consolidation of smart connected healthcare tools with smart homes, encouraging affordable and convenient home-bound patient care. As a testament to the potential of this digital transformation, platforms like Tripolo are ameliorating healthcare accessibility by facilitating personalized patient-provider communication.

Leveraging affordable and clinically validated tools not only reinvents the provision of healthcare but also attunes it to the changing needs of patients, particularly those with chronic conditions or aging in place.

Conclusion

The value of integrating digital tools in RPM is readily apparent in facilitating patient care. Leveraging affordable and clinically validated tools not only reinvents the provision of healthcare but also attunes it to the changing needs of patients, particularly those with chronic conditions or aging in place.

Recommendations

Healthcare professionals should pivot towards adopting digital tools for RPM, placing emphasis on patient-centric care, clinical validation, and affordability of these tools. Platforms like Tripolo can serve as an effective starting point for this transformation. Continuous assessment and improvement of these technological applications will ensure their sustained relevance in improving patient outcomes.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

H
Healthcare

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

H
Healthcare

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512